About: activation syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: activation syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

form of stimulation or agitation that has been observed in association with some psychoactive drugs

Attributes	Values
rdf:type	Item
owl:sameAs	activation syndrome
description	form of stimulation or agitation that has been observed in association with some psychoactive drugs (en)
rdfs:label	Syndrome d'activation (fr) activation syndrome (en) সক্রিয়করণ লক্ষণ (bn) 賦活症候群 (ja)
skos:prefLabel	Syndrome d'activation (fr) activation syndrome (en) সক্রিয়করণ লক্ষণ (bn) 賦活症候群 (ja)
name	Syndrome d'activation (fr) activation syndrome (en) সক্রিয়করণ লক্ষণ (bn) 賦活症候群 (ja)
subclass of	wds:Q4677466-ab7fd514-43da-13fe-8e74-627a70902ec6
subclass of	anxiety
skos:altLabel	アクチベーション・シンドローム (ja) アクチベーション症候群 (ja) アクティベーション・シンドローム (ja) アクティベーション症候群 (ja)
UMLS CUI	wds:Q4677466-1c9b5a88-4f1a-5781-359f-e8adf90160f1
Microsoft Academic ID	wds:Q4677466-2781D93F-E1BF-410A-A85E-6D8EED4C8897
Microsoft Academic ID	https://makg.org/entity/2778044867
UMLS CUI	C1868709
Microsoft Academic ID	2778044867
is about of	activation syndrome https://www.wikidata.org/wiki/Special:EntityData/Q4677466 Activation syndrome https://ja.wikipedia.org/wiki/%E8%B3%A6%E6%B4%BB%E7%97%87%E5%80%99%E7%BE%A4 https://fr.wikipedia.org/wiki/Syndrome_d%27activation https://bn.wikipedia.org/wiki/%E0%A6%B8%E0%A6%95%E0%A7%8D%E0%A6%B0%E0%A6%BF%E0%A6%AF%E0%A6%BC%E0%A6%95%E0%A6%B0%E0%A6%A3_%E0%A6%B2%E0%A6%95%E0%A7%8D%E0%A6%B7%E0%A6%A3
is main subject of	Triple trouble--macrophage activation syndrome in a case of severe leptospirosis and scrub typhus co-infection. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine Macrophage activation syndrome is hemophagocytic lymphohistiocytosis--need for the right terminology Is macrophage activation syndrome a new entity? Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation A rare trigger for macrophage activation syndrome The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis Systematic review: macrophage activation syndrome in inflammatory bowel disease Macrophage activation syndrome in a patient with pulmonary inflammatory myofibroblastic tumour. Macrophage activation syndrome in autoimmune disease Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Coll Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders Macrophage activation syndrome: experience from a tertiary referral centre. Transient multiple cranial nerve involvement as a first sign of macrophage activation syndrome Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. Macrophage activation syndrome, hemophagocytic syndrome Macrophage activation syndrome and cytokine-directed therapies Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis Mast cell activation syndrome: a review Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Mast cell activation syndrome masquerading as agranulocytosis. Polycythemia from mast cell activation syndrome: lessons learned. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. Macrophage activation syndrome in juvenile idiopathic arthritis Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Macrophage activation syndrome induced by A/H1N1 influenza in cystic fibrosis. Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies Incidence and predictors of activation syndrome induced by antidepressants A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids High membrane expression of CD163 by bone marrow cells is not a specific marker of macrophage activation syndrome (MAS). Successful use of Infliximab in macrophage activation syndrome with severe CNS affection Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders Mast cell activation syndrome: Proposed diagnostic criteria. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Recognition and management of macrophage activation syndrome in juvenile arthritis Immunology and clinical manifestations of non-clonal mast cell activation syndrome Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software